Farther Finance Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
2,676
-134
| -5% | -$52.1K | 0.02% | 572 |
|
|
2025
Q1 | $1.22M | Buy |
2,810
+653
| +30% | +$283K | 0.03% | 436 |
|
|
2024
Q4 | $796K | Buy |
2,157
+634
| +42% | +$234K | 0.03% | 441 |
|
|
2024
Q3 | $792K | Buy |
1,523
+317
| +26% | +$165K | 0.03% | 420 |
|
|
2024
Q2 | $645K | Buy |
1,206
+160
| +15% | +$85.5K | 0.03% | 397 |
|
|
2024
Q1 | $540K | Buy |
1,046
+102
| +11% | +$52.6K | 0.03% | 379 |
|
|
2023
Q4 | $445K | Buy |
944
+321
| +52% | +$151K | 0.03% | 374 |
|
|
2023
Q3 | $271K | Buy |
623
+262
| +73% | +$114K | 0.04% | 313 |
|
|
2023
Q2 | $160K | Sell |
361
-10
| -3% | -$4.44K | 0.04% | 348 |
|
|
2023
Q1 | $171K | Buy |
371
+29
| +8% | +$13.3K | 0.05% | 284 |
|
|
2022
Q4 | $175K | Buy |
+342
| New | +$175K | 0.07% | 243 |
|